|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| 21/08 | WINNERS & LOSERS: Hunting falls on outlook cut; miners rise | AN |
| 20/08 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.55% | 0.62% | 35.74x | 22.68x | 12.95x | 26.26x | 27.83x | 1,11900Cr | ||
| 1.99% | 2.08% | 30.06x | - | - | - | - | 65TCr | ||
| 2.59% | 2.72% | 33.82x | -371.14x | 7.82x | 16.26x | 16.9x | 47TCr | ||
| 2.66% | 2.72% | 20.93x | 7.52x | 4.96x | 12.28x | 13.62x | 37TCr | ||
| 2.75% | 2.87% | 22.59x | 6.36x | 5.81x | 14.4x | 15.36x | 30TCr | ||
| 1.99% | 2.11% | 21.37x | 4.8x | 4.4x | 12.49x | 13.21x | 26TCr | ||
| 2.3% | 2.43% | 27.79x | 20.99x | 7.17x | 12.73x | 16.45x | 24TCr | ||
| 3.75% | 3.71% | 13.71x | 5.7x | 4.87x | 10.23x | 11.89x | 21TCr | ||
| 2.26% | 2.32% | -44.65x | 9.95x | 6.45x | 25.18x | 61.67x | 18TCr | ||
| 6.13% | 6.18% | 17.59x | 1.82x | 3.33x | 8.51x | 9.71x | 16TCr | ||
| -.--% | -.--% | 32.32x | 6.18x | 9.34x | 21.11x | 22.02x | 14TCr | ||
| 3.77% | 3.84% | 11.94x | 5.63x | 3.32x | 8.62x | 9.35x | 14TCr | ||
| 5.39% | 5.7% | 12.55x | 1.28x | 2.23x | 7.19x | 8x | 11TCr | ||
| 3.63% | 3.91% | 14.5x | 4.67x | 2.83x | 8.38x | 9.32x | 10TCr | ||
| 1.94% | 2.21% | 22.75x | 5.13x | 7.65x | 14.52x | 15.23x | 7.26TCr | ||
| 3.54% | 3.61% | 46.91x | 1.23x | 2.8x | 9.87x | 29.51x | 5.79TCr | ||
| 0.33% | 1.1% | 20.55x | 1.68x | 1.69x | 7.98x | 13.47x | 5.51TCr | ||
| 0.54% | 0.6% | 34.82x | 4.63x | 8.05x | 27.37x | 28.3x | 4.68TCr | ||
| 2.23% | 2.47% | 18.89x | 1.89x | 3.41x | 12.73x | 14.19x | 4.36TCr | ||
| Average | 2.54% | 2.7% | 20.74x | -14.39x | 5.50x | 14.23x | 18.67x | 24.88TCr | |
| Weighted average by Cap. | 2.15% | 2.25% | 24.70x | -32.16x | 7.59x | 17.16x | 20.37x |
- Stock Market
- Stocks
- GSK Stock
- Stock
- Sector GlaxoSmithKline plc
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















